Where I see patients (2)
My reviews
Selected research
-
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, Plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.
Cancer research communications
-
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.
Nature medicine
-
Investigational Use of Real-World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma from the Randomized Phase Ib/II MORPHEUS Trial.
Clinical pharmacology and therapeutics
4.9